NCT01013597View on ClinicalTrials.gov

Trial of LBH589 in Metastatic Thyroid Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

August 31, 2013

Study Completion Date

February 29, 2016

Conditions
Thyroid Carcinoma
Interventions
DRUG

LBH589

LBH589 20mg by mouth three times weekly (Monday/Wednesday/Friday) for 28-day cycles.

Trial Locations (3)

53226

Medical College of Wisconsin, Milwaukee

53792

University of Wisconsin - Madison, Madison

54301

St. Vincent Regional Cancer Center CCOP, Green Bay

Sponsors

Collaborators (1)

Novartis Pharmaceuticals
All Listed Sponsors
collaborator

Novartis Pharmaceuticals

INDUSTRY

lead

University of Wisconsin, Madison

OTHER